BARCLAYS PLC - CATABASIS PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of CATABASIS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2021$11,000
-89.7%
5,311
-85.6%
0.00%
Q1 2021$107,000
+87.7%
36,926
+39.2%
0.00%
Q4 2020$57,000
+5.6%
26,534
+203.0%
0.00%
Q3 2020$54,000
-15.6%
8,758
-11.7%
0.00%
Q2 2020$64,0009,9130.00%
Other shareholders
CATABASIS PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Eversept Partners, LP 522,042$1,117,1700.13%
XTX MARKETS LLC 26,041$56,0000.12%
Samsara BioCapital, LLC 300,000$642,0000.06%
Ikarian Capital, LLC 650,000$1,392,0000.06%
Opaleye Management Inc. 187,750$402,0000.05%
SABBY MANAGEMENT, LLC 108,026$231,0000.04%
Anson Funds Management LP 97,601$209,0000.04%
Virtu Financial LLC 83,221$178,0000.02%
GSA CAPITAL PARTNERS LLP 47,084$101,0000.02%
WEXFORD CAPITAL LP 19,512$42,0000.01%
View complete list of CATABASIS PHARMACEUTICALS IN shareholders